Published in Swiss Med Wkly on May 01, 2010
Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark. PLoS One (2014) 0.89
Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test. BMC Infect Dis (2012) 0.84
Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patients. PLoS One (2013) 0.79
Interferon-gamma release assays are a better tuberculosis screening test for hemodialysis patients: A study and review of the literature. Can J Infect Dis Med Microbiol (2012) 0.77
A retrospective review of the two-step tuberculin skin test in dialysis patients. Can J Kidney Health Dis (2016) 0.75
The interferon-gamma-based QuantiFERON-TB Gold in-tube test and the type of hemodialysis process. Swiss Med Wkly (2010) 0.75
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature (1984) 3.71
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95
Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant (2007) 2.15
Fatal outcome of renal transplantation in a patient with the Wiskott-Aldrich syndrome. Nephrol Dial Transplant (1996) 2.11
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med (1991) 2.10
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol (1985) 1.88
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (2003) 1.76
Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (2000) 1.69
Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol (2000) 1.60
Clinical relevance of cytomegalovirus viraemia(*,†). HIV Med (2011) 1.55
Cerebrospinal fluid immunoglobulins and multiple sclerosis. Correspondence with magnetic resonance imaging and visually evoked potential changes. Arch Neurol (1989) 1.44
Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. J Gastroenterol Hepatol (1998) 1.41
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis (1998) 1.11
Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study. J Clin Microbiol (1996) 1.09
Supposed lamarckian inheritance of immunological tolerance. Nature (1981) 1.05
Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol (1991) 1.04
Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS (1999) 1.01
Images of asteroid 21 Lutetia: a remnant planetesimal from the early Solar System. Science (2011) 0.99
Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-gamma. J Neuroimmunol (1986) 0.97
Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients. J R Soc Interface (2005) 0.96
Non-H-2 and H-2-linked immune response genes control the cytotoxic T-cell response to H-Y. Immunogenetics (1982) 0.95
Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy. AIDS Res Hum Retroviruses (2010) 0.95
T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability. Eur J Immunol (1992) 0.92
The endothelium--astrocyte immune control system of the brain. Springer Semin Immunopathol (1985) 0.92
Genetic analysis of the non-H-2-linked Ir genes controlling the cytotoxic T-cell response to H-Y in H-2d mice. Immunogenetics (1982) 0.89
Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med (1995) 0.89
Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study. Ann Neurol (1988) 0.88
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. HIV Med (2008) 0.88
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study. AIDS (1999) 0.88
Electrophysiological investigations in adoptively transferred experimental autoimmune encephalomyelitis in the Lewis rat. Brain (1989) 0.88
Immune reactivity of progeny of tetraparental male mice. Nature (1981) 0.88
Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly (2009) 0.87
Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies. J Neuroimmunol (2007) 0.87
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis (2015) 0.86
T cell approach to demyelinating diseases. Springer Semin Immunopathol (1985) 0.85
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis (2014) 0.85
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infect Dis (2015) 0.84
Immune mechanisms in inflammatory polyneuropathy. Ann N Y Acad Sci (1988) 0.84
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med (2010) 0.84
The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol (1990) 0.84
[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH]. Schweiz Med Wochenschr (1996) 0.84
Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland. Int J Infect Dis (2002) 0.83
Importance of mental health assessment in HIV-infected outpatients. J Acquir Immune Defic Syndr (2001) 0.83
The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line. Ann Neurol (1988) 0.83
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV Med (2010) 0.83
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infect Dis (2011) 0.83
Gender imbalance in living kidney donation in Switzerland. Transplant Proc (2005) 0.82
Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Infection (2005) 0.82
Specific haplotype preference in congenic F1 hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y. J Immunol (1981) 0.82
Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Vet Immunol Immunopathol (1992) 0.82
Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma. Br J Cancer (1991) 0.82
High proportion of gamma-delta T cell receptor positive T cells in bronchoalveolar lavage and peripheral blood of HIV-infected patients with Pneumocystis carinii pneumonias. Respiration (1993) 0.80
Detection of drug-resistant HIV minorities in clinical specimens and therapy failure. HIV Med (2008) 0.80
Further studies on supposed lamarckian inheritance of immunological tolerance. Nature (1982) 0.80
BKV replication and cellular immune responses in renal transplant recipients. Am J Transplant (2006) 0.80
Hodgkin's disease and cadaveric renal transplantation. Transplant Proc (1995) 0.80
Diagnostic yield of bronchoalveolar lavage following renal transplantation. Transpl Infect Dis (2001) 0.80
Using a neural network to identify potential HLA-DR1 binding sites within proteins. J Mol Recognit (1993) 0.79
Sodium balance-neutral sodium profiling does not improve dialysis tolerance. Swiss Med Wkly (2001) 0.79
How reliable is an undetectable viral load? HIV Med (2009) 0.79
A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss Med Wkly (2008) 0.79
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir. HIV Med (2014) 0.78
Immunodeficiency after major trauma and selective surgery. Pediatr Infect Dis J (1988) 0.78
Suppression of P2-T cell line-mediated experimental autoimmune neuritis by interleukin-2 receptor targeted monoclonal antibody ART 18. Brain Res (1989) 0.78
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy. Swiss Med Wkly (2001) 0.78
Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infect Dis (2015) 0.78
On the role of astrocytes in polyclonal T cell activation. J Neuroimmunol (1986) 0.78
Transplantation-associated Kaposi's sarcoma: herpesvirus 8 transmission through renal allografts. Transplant Proc (1999) 0.78
Granulomatous Pneumocystis carinii pneumonia in Wegener's granulomatosis. Eur Respir J (2000) 0.77
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study. HIV Med (2002) 0.77
[The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons]. Dtsch Med Wochenschr (1993) 0.77
Occupational risk assessment of aspergillosis after renal transplantation. Transpl Infect Dis (2007) 0.76
[The Swiss Organ Living Donor Health Registry (SOL-DHR)]. Ther Umsch (2005) 0.76
Heterogeneous binding and killing behaviour of human gamma/delta-TCR+ lymphokine-activated killer cells against K562 and Daudi cells. Cancer Immunol Immunother (1993) 0.76
Genital shedding of HIV after scheduled treatment interruption. Int J STD AIDS (2011) 0.76
Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain (1991) 0.76
Diagnostics and treatment of HIV-affected couples who wish to have children. Eur J Med Res (2008) 0.76
Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceive. Hum Reprod (2007) 0.76
H1N1 pandemic: watch out for the first wave in Switzerland. Swiss Med Wkly (2009) 0.75
Areas of sequence homology between several staphylococcal exotoxin "superantigens" and the HIV-1 pol protein. AIDS Res Hum Retroviruses (1992) 0.75
Early detection of HIV in neonates. N Engl J Med (1993) 0.75
Sensitization to human immunodeficiency virus in seronegative exposed partners. J Infect Dis (2000) 0.75
Conception of an XML-based ontology for a Web-based medical information service. Stud Health Technol Inform (2000) 0.75
An electronic study form to support collaborating agents in the management of clinical knowledge. Methods Inf Med (1999) 0.75
Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. Arch Dermatol (1995) 0.75
The Sézary syndrome. Dermatologica (1979) 0.75
[Disseminated mycobacteriosis with M. kansasii in a case of AIDS without HIV infection]. Schweiz Med Wochenschr (1997) 0.75
T cell response to staphylococcal superantigens by asymptomatic HIV-infected individuals exhibits selective changes in T cell receptor V beta-chain usage. AIDS Res Hum Retroviruses (1993) 0.75
[HIV test and prevention]. Internist (Berl) (2012) 0.75